Kris Kupumbati | President, MedTech Leader

At Onecrea Medical, Kris Kupumbati leads the development of next-gen cardiovascular devices to enhance patient care and outcomes.

https://onecreamedical.com/

Onecrea Medical – Transforming Heart Valve Treatment

Specializing in TAVI procedures, Onecrea Medical provides innovative aortic valve solutions designed for precision and durability. Their technology supports cardiologists in delivering safe, effective, and minimally invasive heart treatments.

https://onecreamedical.com/

Why the Crea Aortic Valve Offers the Best Prospects for Patients at High Risk for Surgery

Heart disease poses serious challenges when it impacts the aortic valve, particularly in cardiology patients. Traditional open-heart surgery to replace the valve can be risky, especially for older individuals or those with existing health conditions. The Crea Aortic Valve represents a significant medical advancement, providing a safer alternative for patients who face high risks with conventional surgery.

https://onecreamedical.blogspo....t.com/why-crea-aorti

Why the Crea Aortic Valve is the Best Hope for Patients with High Surgical Risk

Heart disease creates major problems when it affects the aortic valve in cardiology patients. Standard open-heart surgery to replace a damaged valve becomes dangerous for patients with aortic valve disease especially when they are older or suffer from health problems. The Crea Aortic Valve proves an important medical breakthrough by offering safer treatment to people with high surgery risks.

https://onecreamedical.blogspo....t.com/why-crea-aorti

Aortic Valve Replacement: A Life-Saving Procedure for Heart Health

The aortic valve plays a vital role in ensuring proper blood circulation throughout the body. It allows oxygen-rich blood from the heart to flow into the arteries and reach various organs and tissues. If the aortic valve doesn't function correctly, it can lead to serious conditions such as heart failure or a heart attack.

https://onecreamedicalblog.wor....dpress.com/2025/04/0